Insider Trading29 Jun 2026, 04:40 pm
Samrat Pharmachem Closes Trading Window for Q1 FY27 Results
AI Summary
Samrat Pharmachem Ltd has announced the closure of its trading window for all designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will be shut from Wednesday, July 1, 2026, until 48 hours after the declaration of the Un-Audited Financial Results for the quarter ended June 30, 2026. During this period, no insider is permitted to trade in the company's shares, especially if in possession of Unpublished Price Sensitive Information.
Key Highlights
- Trading window closed for Q1 FY27 results announcement.
- Effective from July 1, 2026, until 48 hours post-results.
- Applies to all designated persons and immediate relatives.
- Prohibits trading in company shares during the closure period.
- Compliance with SEBI Insider Trading Regulations.
Price Impact
More from SAMRATPH